J. Paul Abernathy - 15 Jan 2026 Form 4 Insider Report for NATIONAL HEALTHCARE CORP (NHC)

Role
Director
Signature
/s/ James Paul Abernathy
Issuer symbol
NHC
Transactions as of
15 Jan 2026
Net transactions value
+$4,865
Form type
4
Filing time
16 Jan 2026, 16:01:48 UTC
Previous filing
15 Aug 2025
Next filing
10 Mar 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
ABERNATHY JAMES PAUL Director 1523 MIRABELLA WAY, MURFREESBORO /s/ James Paul Abernathy 16 Jan 2026 0001261687

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NHC Shares of Common Stock Options Exercise $523,650 +7,500 +21% $69.82 43,894 15 Jan 2026 Direct F1
transaction NHC Shares of Common Stock Tax liability $518,785 -3,732 -8.5% $139.01 40,162 15 Jan 2026 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NHC Option to Purchase Common Stock [2022 Grant] Options Exercise $0 -7,500 -100% $0.000000 0 15 Jan 2026 Common Stock 7,500 $69.19 Direct F1
holding NHC Option to Purchase Common Stock [2023 Grant] 7,500 15 Jan 2026 Common Stock 7,500 $55.75 Direct
holding NHC Option to Purchase Common Stock [2024 Grant] 7,500 15 Jan 2026 Common Stock 7,500 $96.03 Direct
holding NHC Option to Purchase Common Stock [2025 Grant] 7,500 15 Jan 2026 Common Stock 7,500 $94.66 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 5, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
F2 Shares were withheld by the Company to pay the exercise price.
F3 Total amount of shares beneficially owned following transactions reported on this form.